Vistra Energy (VST) Buy Rating Reconfirmed by Analysts at Bank of America; With $27 Target; 13 Analysts Covering Laboratory of America Holdings (LH)

April 17, 2018 - By Peter Erickson

Laboratory Corporation of America Holdings (NYSE:LH) Logo

In an analyst report sent to investors and clients on Tuesday morning, Vistra Energy (VST) stock had its Buy Rating kept by analysts at Bank of America. They currently have a $27 price target on firm. Bank of America’s target would suggest a potential upside of 21.79% from the company’s last stock price.

Among 20 analysts covering Laboratory Corp (NYSE:LH), 13 have Buy rating, 0 Sell and 7 Hold. Therefore 65% are positive. Laboratory Corp had 64 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was initiated by Citigroup on Friday, September 9 with “Neutral”. As per Thursday, March 1, the company rating was maintained by Credit Suisse. On Tuesday, August 16 the stock rating was maintained by KeyBanc Capital Markets with “Overweight”. Canaccord Genuity maintained the shares of LH in report on Wednesday, January 3 with “Buy” rating. The firm earned “Neutral” rating on Tuesday, April 26 by UBS. Piper Jaffray maintained Laboratory Corporation of America Holdings (NYSE:LH) rating on Monday, September 4. Piper Jaffray has “Buy” rating and $186.0 target. Wells Fargo upgraded it to “Buy” rating and $175.0 target in Thursday, October 12 report. Mizuho maintained the stock with “Neutral” rating in Wednesday, July 29 report. The rating was maintained by Robert W. Baird on Friday, September 1 with “Hold”. The firm has “Overweight” rating given on Wednesday, February 28 by Morgan Stanley. See Laboratory Corporation of America Holdings (NYSE:LH) latest ratings:

23/03/2018 Broker: Argus Research Rating: Buy New Target: $202 Initiates Coverage On
08/03/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $192 New Target: $195 Maintain
06/03/2018 Broker: Jefferies Rating: Hold New Target: $176.0 Maintain
28/02/2018 Broker: SunTrust Rating: Buy New Target: $210.0 Maintain
01/03/2018 Broker: Credit Suisse Old Rating: Outperform New Rating: Outperform Old Target: $190 New Target: $192 Maintain
28/02/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $182 New Target: $192 Maintain
28/02/2018 Broker: Canaccord Genuity Old Rating: Buy New Rating: Buy Old Target: $190 New Target: $195 Maintain
26/02/2018 Broker: Barclays Capital Old Rating: Overweight New Rating: Overweight Old Target: $195 New Target: $210 Maintain
09/02/2018 Broker: Citigroup Old Rating: Neutral New Rating: Neutral Old Target: $161 New Target: $184 Maintain
08/02/2018 Broker: Robert W. Baird Rating: Hold New Target: $183.0 Maintain

The stock increased 0.82% or $0.18 during the last trading session, reaching $22.17. About 3.09 million shares traded. Vistra Energy Corp. (VST) has risen 31.61% since April 17, 2017 and is uptrending. It has outperformed by 20.06% the S&P500.

Among 11 analysts covering Vistra Energy (VST), 10 have Buy rating, 0 Sell and 1 Hold. Therefore 91% are positive. Vistra Energy has $3700 highest and $16 lowest target. $23.05’s average target is 3.97% above currents $22.17 stock price. Vistra Energy had 20 analyst reports since June 8, 2017 according to SRatingsIntel. The firm has “Buy” rating by RBC Capital Markets given on Thursday, February 1. As per Monday, April 9, the company rating was maintained by Guggenheim. The stock of Vistra Energy Corp. (NYSE:VST) has “Hold” rating given on Monday, January 22 by SunTrust. On Wednesday, October 18 the stock rating was maintained by SunTrust with “Hold”. UBS upgraded Vistra Energy Corp. (NYSE:VST) rating on Tuesday, March 6. UBS has “Buy” rating and $27 target. The company was maintained on Tuesday, February 27 by SunTrust. The company was initiated on Tuesday, October 24 by Bank of America. The firm has “Buy” rating by Citigroup given on Thursday, September 28. The stock has “Buy” rating by RBC Capital Markets on Sunday, April 8. Evercore initiated the shares of VST in report on Friday, October 20 with “Buy” rating.

Vistra Energy Corp., an energy company, engages in integrated power business in Texas. The company has market cap of $11.59 billion. The firm operates through two divisions, Wholesale Generation and Retail Electricity. It currently has negative earnings. The Wholesale Generation segment engages in the electricity generation, wholesale energy sales and purchases, commodity risk management activities, fuel production, and fuel logistics management activities.

Analysts await Vistra Energy Corp. (NYSE:VST) to report earnings on May, 17. They expect $0.35 EPS, up 94.44% or $0.17 from last year’s $0.18 per share. VST’s profit will be $183.02 million for 15.84 P/E if the $0.35 EPS becomes a reality. After $0.13 actual EPS reported by Vistra Energy Corp. for the previous quarter, Wall Street now forecasts 169.23% EPS growth.

Laboratory Corporation of America Holdings operates as an independent clinical laboratory firm worldwide. The company has market cap of $16.98 billion. It operates through two divisions, LabCorp Diagnostics and Covance Drug Development. It has a 13.63 P/E ratio. The firm offers a range of clinical laboratory tests and procedures, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, hemoglobin A1C, PSA, tests for sexually-transmitted diseases, HCV tests, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests that are used by hospitals, physicians and other healthcare providers and commercial clients to assist in the diagnosis, monitoring and treatment of diseases and medical conditions through the examination of substances in blood, tissues, and other specimens.

The stock decreased 0.05% or $0.08 during the last trading session, reaching $166.42. About 267,604 shares traded. Laboratory Corporation of America Holdings (NYSE:LH) has risen 14.17% since April 17, 2017 and is uptrending. It has outperformed by 2.62% the S&P500.

Investors sentiment increased to 1.2 in 2017 Q4. Its up 0.30, from 0.9 in 2017Q3. It increased, as 36 investors sold Laboratory Corporation of America Holdings shares while 209 reduced holdings. 73 funds opened positions while 220 raised stakes. 91.47 million shares or 0.35% less from 91.79 million shares in 2017Q3 were reported. Birch Hill Investment Advsrs Ltd Liability holds 0.75% or 57,012 shares. Farmers Merchants owns 173 shares for 0% of their portfolio. Hillsdale Mgmt Inc holds 0% in Laboratory Corporation of America Holdings (NYSE:LH) or 50 shares. The Korea-based Natl Pension has invested 0.09% in Laboratory Corporation of America Holdings (NYSE:LH). Jacobs Ca holds 0.66% or 23,389 shares. Pictet Asset Ltd has 0.02% invested in Laboratory Corporation of America Holdings (NYSE:LH) for 59,290 shares. Amundi Pioneer Asset Mngmt reported 132,182 shares stake. Holderness Invs stated it has 4,545 shares or 0.36% of all its holdings. Gam Holdings Ag accumulated 21,664 shares. Barry Inv Advsr Ltd Com has invested 0.53% in Laboratory Corporation of America Holdings (NYSE:LH). Creative Planning owns 0.01% invested in Laboratory Corporation of America Holdings (NYSE:LH) for 7,430 shares. Ghp Invest Advsr holds 12,627 shares. Whittier Trust Com holds 502 shares or 0% of its portfolio. Buckingham Capital Mngmt Inc invested in 5,485 shares. Peapack Gladstone Corp stated it has 91,786 shares.

Since October 30, 2017, it had 0 insider purchases, and 5 selling transactions for $10.55 million activity. $548,124 worth of Laboratory Corporation of America Holdings (NYSE:LH) was sold by ANDERSON KERRII B on Friday, February 9. Schechter Adam H sold $213,813 worth of stock or 1,263 shares. On Friday, March 23 KING DAVID P sold $8.23 million worth of Laboratory Corporation of America Holdings (NYSE:LH) or 49,967 shares. Gilliland Dwight Gary sold $149,068 worth of stock or 971 shares. 8,400 Laboratory Corporation of America Holdings (NYSE:LH) shares with value of $1.41 million were sold by EISENBERG GLENN A.

Laboratory Corporation of America Holdings (NYSE:LH) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>